|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/48 | |
| A61P 25/02 |
| (11) | Patento numeris | 2280719 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09734803.1 |
| Europos patento paraiškos padavimo data | 2009-04-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-02-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-09-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2009/005750 |
| Data | 2009-04-27 |
| (87) | Numeris | WO 2009/130600 |
| Data | 2009-10-29 |
| (30) | Numeris | Data | Šalis |
| 0802321 | 2008-04-25 | FR |
| (72) |
FAVRE, Christine, FR
AUGUET, Michel, FR
CHABRIER DE LASSAUNIERE, Pierre-Etienne, FR
|
| (73) |
IPSEN PHARMA S.A.S.,
65, Quai Georges Gorse, 92100 Boulogne-Billancourt,
FR
|
| (54) | THERAPEUTIC USE OF BOTULINUM NEUROTOXIN TYPE A IN THE TREATMENT OF PAIN ASSOCIATED WITH DIABETIC NEUROPATHY |
| THERAPEUTIC USE OF BOTULINUM NEUROTOXIN TYPE A IN THE TREATMENT OF PAIN ASSOCIATED WITH DIABETIC NEUROPATHY |